Cigna Group (CI) Projected to Post Earnings on Thursday

Key Points

• Cigna is expected to report Q3 2026 results before markets open November 5. Analysts project earnings of $7.52 per share on $72.64 billion in revenue.
• The company’s previous quarter exceeded expectations, with EPS of $7.78 versus $7.60 forecast and revenue of $71.56 billion, up 6.7% year over year.
• Analyst sentiment remains generally positive, with a “Moderate Buy” consensus and an average price target of $338.24, although Jefferies recently downgraded the stock to “Hold.”

Cigna Group (NYSE:CI - Get Free Report) is expected to be releasing its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect Cigna Group to post earnings of $7.52 per share and revenue of $72.64 billion for the quarter. Interested persons may visit the company's upcoming Q3 2026 earnings report for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:30 AM ET.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $71.56 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the previous year, the firm earned $7.20 EPS. The company's quarterly revenue was up 6.7% compared to the same quarter last year. On average, analysts expect Cigna Group to post $30.49 EPS for the current fiscal year and $33.51 EPS for the next fiscal year.

Cigna Group Stock Down 1.2%

Shares of NYSE CI opened at $294.76 on Thursday. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 12 month low of $239.51 and a 12 month high of $316.27. The firm has a market capitalization of $77.89 billion, a PE ratio of 12.20, a price-to-earnings-growth ratio of 1.04 and a beta of 0.29. The firm has a fifty day simple moving average of $282.97 and a two-hundred day simple moving average of $281.33.

Insider Transactions at Cigna Group

In other news, insider Everett Neville sold 617 shares of the business's stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the sale, the insider directly owned 5,053 shares of the company's stock, valued at $1,435,304.65. The trade was a 10.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,677 shares of the business's stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider directly owned 25,880 shares in the company, valued at approximately $7,236,306.80. This represents a 9.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 22,730 shares of company stock worth $6,293,359. Corporate insiders own 0.60% of the company's stock.

Cigna Group News Summary

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna declared a quarterly cash dividend of $1.56 per share, payable December 17 to shareholders of record on December 3. The payment reinforces shareholder returns and signals continued financial stability, although the unchanged dividend may already be reflected in the stock. The Cigna Group Declares Quarterly Dividend
• Positive Sentiment: Piper Sandler reiterated a $370 price target, suggesting substantial potential upside from recent trading levels and continued analyst confidence in Cigna’s valuation. Piper Sandler Reiterates $370 Target
• Neutral Sentiment: Cigna scheduled its next quarterly results for November 5. The report is likely to be the next significant catalyst, particularly for guidance, medical-cost trends, client retention and profitability. Cigna Sets November 5 Results Date
• Neutral Sentiment: Recent analysis argues that retaining clients is less important than ensuring contracts are profitable. This keeps investor focus on the quality of Cigna’s earnings and margins rather than enrollment growth alone. Client Retention Matters, But Contract Profitability Matters More
• Negative Sentiment: A newly introduced House bill would impose stricter prior-authorization deadlines, greater benefit transparency, limits on midyear coverage changes, reimbursement requirements and penalties for billing errors. Cigna could face higher administrative and compliance costs if the proposal advances, though it currently has no cosponsors and most healthcare provisions would not take effect until 2029. Ending Patient Runaround Act

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on CI. Jefferies Financial Group lowered shares of Cigna Group from a "buy" rating to a "hold" rating and cut their target price for the company from $336.00 to $307.00 in a research note on Tuesday, August 4th. Barclays increased their price target on shares of Cigna Group from $304.00 to $310.00 and gave the stock an "equal weight" rating in a research note on Friday, July 31st. Evercore initiated coverage on shares of Cigna Group in a report on Wednesday, September 9th. They issued an "in-line" rating and a $290.00 price objective for the company. Royal Bank Of Canada restated an "outperform" rating and issued a $337.00 price objective on shares of Cigna Group in a report on Thursday, October 1st. Finally, UBS Group reaffirmed a "buy" rating on shares of Cigna Group in a research report on Thursday, October 1st. Fifteen analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $338.24.

Cigna Group Company Profile

The Cigna Group NYSE: CI is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.